Impact of novel P2Y12 receptor inhibitors on platelet reactivity in acute coronary syndrome patients undergoing percutaneous coronary intervention / 中华心血管病杂志

<p><b>OBJECTIVE</b>To investigate the impact of novel P2Y(12) receptor inhibitors including prasugrel or ticagrelor on platelet reactivity in patients with acute coronary syndrome (ACS) receiving percutaneous coronary intervention (PCI), and provide clinical data for novel oral P2Y(12) receptor inhibitors use among Chinese patients.</p><p><b>METHODS</b>Between October 2011 to February 2014, 174 consecutive patients (135 males; (67.8±11.8) years old) with ACS undergoing PCI in Kiang Wu Hospital, Macau were prospectively enrolled in this study. Oral aspirin and one P2Y(12) receptor inhibitor were administered for 5 days or above after PCI, patients were divided into clopidogrel, prasugrel and ticagrelor groups in accordance with the agent administered. Platelet reactivity of the patients was detected by VerifyNow P2Y(12) reaction unit (PRU); and the high on-treatment platelet reactivity (HPR) and non-HPR were defined as PRU≥208 and PRU<208 respectively. Patients with HPR during clopidogrel therapy were switched either to prasugrel or ticagrelor, or continued the same treatment; and then the platelet reactivity was monitored again.</p><p><b>RESULTS</b>There were 113 clopidogrel cases (64.9%), 20 prasugrel cases (11.5%) and 41 ticagrelor cases (23.6%). Fifty-seven cases (32.8%) were defined as HPR post P2Y(12) receptor inhibitor use, in which 55 cases (55/113, 48.7%) were treated with clopidogrel. The degree of inhibition of platelet reactivity was significantly different in patients on clopidogrel, prasugrel and ticagrelor therapy, percent inhibition assayed by the VerifyNow P2Y(12) system was 28.2%±23.5%, 61.4%±26.7% and 81.3%±19.8% respectively (P<0.05). Different degree of platelet reactivity was achieved by the 3 P2Y(12) receptor inhibitors at multiple time points. The among-group differences in platelet reactivity became apparent at the early treatment stage (P<0.05). Platelet aggregation decreased significantly in patients switched from clopidogrel to prasugrel or ticagrelor (P<0.05).</p><p><b>CONCLUSION</b>Novel oral P2Y(12) receptor inhibitors are more effective in inhibiting platelet reactivity in ACS patients, and our results show that novel oral P2Y(12) receptor inhibitors provide a new option for ACS patients with HPR post clopidogrel or high-risk features of ischemic complications, including stent thrombosis and post-PCI ischemic events.</p>

Microbial community changes in contaminated soils in response to phenanthrene amendment

Leachate and reclaimed wastewater have become the important sources of polycyclic aromatic hydrocarbons in soils. However, the information on bioremediation of leachate and reclaimed wastewater-contaminated soils is still lacking. Identification of changes in microbial structure or of enriched genera related to biodegradation could aid identification of particular organisms or consortia capable of degrading polycyclic aromatic hydrocarbons in these contaminated soils. In this study, terminal restriction fragment length polymorphism, coupled with 16S Ribosomal ribonucleic acid clone library analysis, was applied to investigate the composition of bacterial community in leachate-contaminated soil or grassland soil irrigated reclaimed wastewater and the response to phenanthrene amendment. Results showed that phenanthrene amendment had significant but different impacts on microbial community structure, dependent on soil source. Several greatly enriched terminal restriction fragments with phenanthrene biodegradation were identified. Moreover, genus rhizobacteria, possibly linked to phenanthrene biodegradation, was firstly reported in this study. This work might provide some new insights into bioremediation of polycyclic aromatic hydrocarbons-contaminated soils

Chemical constituents of Hedysarum polybotrys Hand.-Mazz / 中国中药杂志

Butanedioic acid was isolated from the ethyl alcohol extract of Hedysarum polybotrys. The methylated carboxylic acid was identified by GC-MS method.